Reading time:2 mins, 55 seconds
Digestive Balloons, also known as Intragastric Balloon Therapy, are the semi-permanent solution inserted into the stomach wall and inflate to gently train you to improve your digestion. The Global Intragastric Balloons Market report provides market landscape insights by study type, technology, and launch date.
What is an intragastric balloon (BG, CO2)?
An intragastric balloon (BG, CO2) is a device inserted into a person’s stomach to help reduce the amount of oxygen in the body by changing breathing patterns. It has become popular mainly in the last five years.
How big will the market be by 2025?
The global market for intragastric balloons for the treatment of obesity is expected to grow at a CAGR of approximately 4.4% during the period 2017-2025, reaching USD 6.71 billion by 2025. During this period, the Developed regions and technologies will dominate the global market, followed by developing regions, RESEARCH & ANALYSIS SUMMARY.
Description of the intra-gastric balloon
An intragastric balloon is a lightweight, inflatable helical device designed to be filled with water, used as an intestinal balloon in the digestive tract connected to the stomach. The balloon can be introduced through the mouth or nose and inflated once inside the stomach. It can be used for medical purposes, such as correcting fluid imbalance and/or gastrointestinal obstruction or dysfunction, preventing reflux esophagitis, or weight loss.
Key Market Drivers
Views from Logica Advisors on the Intragastric Balloons Market Growing demand for weight management and patients with gastrointestinal disorders is the main driver of the market. As a result, the global intragastric balloon market is expected to grow at a significant CAGR.
Click on the tab below to benefit from the sample copy of the report
Impact analysis by assumptions
Biliary stenting is a safe, long-lasting and effective medical treatment for benign obstructions of the common bile duct. However, there is plenty of room for improvement, including minimizing the invasiveness of the procedure and requiring single-device surgery. Nevertheless, biliary stenting offers an excellent option for patients with mild bile duct obstructions that do not require surgery in their treatment, while avoiding liver transplantation.
The global market for intragastric balloons is constantly growing. In 2013, the global intragastric balloon market value was US$125.9 million, while in 2015 it was growing at a CAGR of 6.5%.
Attracting new investors, EndoLARGEBIRTHS and online amplification methods
The intragastric balloon market has recently witnessed an increase in popularity due to the introduction and commercialization of this type of technology. Providing an in-office endoscopy procedure, the intragastric balloon offers a highly detailed approach to achieving therapeutic results with minimal complications.
Demand in Emerging Asia-Pacific Markets Driving Intragastric Balloon Market Growth
The Intragastric Balloon Market research report presents an in-depth examination of this market. It also details the main global players in the sector, such as Johnson & Johnson, Abbott Laboratories and Novo Nordisk. Additionally, it highlights the geographic revenue breakdown for current and projected sales to 2023 by regions, end-user segments and key players at a detailed geographic level.
Click on the tab below for the instant purchase of the report with a flat rate discount of $500
Instant Buy Request
Main actors of Intragast
Intragastric Balloons Market analysis report by study type, technology and launch date provides an in-depth balance forecast and SWOT analysis for the key players involved in this market.
An extensive content offering is provided for all geographies and various products in each curated market segment.